Fact CheckerSign in

NCT07278336RecruitingPhase 1

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination with Bevacizumab in Adult Participants with Ovarian Cancer

Source: EU CTIS (euclinicaltrials.eu) · Last updated 28 Aug 2026

Status (registry)
Recruiting
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
44 (estimated)
First submitted
31 Mar 2026
Start date
10 Aug 2026
Lead sponsor
AbbVie Deutschland GmbH & Co. KG
NCT number
NCT07278336
EU CT number
2025-522209-40-00

What you commit to

  • Study type: Interventional · Phase 1
  • Planned participants: 44
  • 10 sites in 4 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Sites (10)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Rigshospitalet
Coordinator of this site? Confirm its status
Copenhagen OeDenmarkNot yet recruiting
Hospital Universitari Vall d'Hebron
Coordinator of this site? Confirm its status
BarcelonaSpainRecruiting
Hospital Universitario Fundación Jiménez Díaz
Coordinator of this site? Confirm its status
MadridSpainRecruiting
Hospital Universitario HM Sanchinarro
Coordinator of this site? Confirm its status
MadridSpainRecruiting
Hospital Universitario Puerta de Hierro de Majadahonda
Coordinator of this site? Confirm its status
MajadahondaSpainRecruiting
Centre Leon Berard
Coordinator of this site? Confirm its status
LyonFranceRecruiting
Institut De Cancerologie De L Ouest
Coordinator of this site? Confirm its status
Saint-Herblain CedexFranceRecruiting
Institut Gustave Roussy
Coordinator of this site? Confirm its status
VillejuifFranceRecruiting
Unidade Local De Saude De Santa Maria E.P.E.
Coordinator of this site? Confirm its status
LisbonPortugalRecruiting
Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E.
Coordinator of this site? Confirm its status
PortoPortugalRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.